Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08XFJ
|
|||
| Former ID |
DIB001947
|
|||
| Drug Name |
NN-1218
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 1 | [1] | |
| Type-1 diabetes [ICD-11: 5A10; ICD-9: 250] | Application submitted | [2], [3] | ||
| Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Application submitted | [2] | ||
| Company |
Novo Nordisk A/S
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01121289) A Trial Investigating NN1218 in Subjects With Type 1 Diabetes. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Ultrafast-Acting Insulins: State of the Art. J Diabetes Sci Technol. 2012 July; 6(4): 728-742. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.